(Q44432850)

2 December 2017

title

Effects of oral montelukast on airway function in acute asthma (English)

1 reference

2 December 2017

1 reference

A. Cýllý

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12735671

31 December 2023

A. Kara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12735671

31 December 2023

T. Ozdemir

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12735671

31 December 2023

C. Oğüş

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12735671

31 December 2023

K. H. Gülkesen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12735671

31 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12735671

31 December 2023

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

https://doi.org/10.1053/rmed.2003.1479

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12735671

https://api.elsevier.com/content/article/PII:S095461110391479X?httpAccept=text/xml

31 December 2023

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

https://api.elsevier.com/content/article/PII:S095461110391479X?httpAccept=text/plain

31 December 2023

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

31 December 2023

1 reference

2 December 2017

volume

97

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

533-536

1 reference

2 December 2017

1

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma

31 December 2023

2

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

Effects of antileukotrienes in the treatment of asthma

31 December 2023

3

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

31 December 2023

4

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

Steroids in Acute Exacerbation of Asthma

31 December 2023

5

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

Corticosteroids in the emergency department therapy of acute adult asthma: an evidence-based evaluation

31 December 2023

6

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

Early parenteral corticosteroid administration in acute asthma

31 December 2023

7

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

Observations on the effects of aerosolized albuterol in acute asthma

31 December 2023

8

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma. Canadian Combivent Study Group

31 December 2023

9

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

Emergency room of treatment of asthma. Relationships among therapeutic combinations, severity of obstruction and time course of response

31 December 2023

10

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

31 December 2023

12

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

Acute bronchodilation with an intravenously administered leukotriene D4 antagonist, MK-679

31 December 2023

13

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma

31 December 2023

14

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma

31 December 2023

15

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females.

31 December 2023

16

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

31 December 2023

Intravenous montelukast

17

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients

31 December 2023

18

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

Induced Sputum Eicosanoid Concentrations in Asthma

31 December 2023

19

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

Leukotriene receptor antagonists: useful in acute asthma?

31 December 2023

20

1 reference

https://api.crossref.org/works/10.1053/RMED.2003.1479

31 December 2023

Identifiers

1 reference

2 December 2017

1 reference